Search

Learn how GSK graduate Dr. Ellen Horste’s time investigating fundamental biological questions prepared her for a career in the emerging field of gene therapy.

… Friday, July 12, 2024 Ellen Horste’s job is a little bit like packing for Mars — where every efficiency and every little bit of room that can be saved matter. As a payload engineer for a gene therapy startup, Dr. Horste designs genetic elements that get loaded into a virus for delivery into the human

Learn more about five essential strategies for coping with the fear of cancer, from MSK psychiatrist Dr. Monique James.

… Thursday, November 20, 2025 There’s no doubt about it: Cancer is scary. But the fear of cancer, sometimes called “carcinophobia,” can cause significant distress. You may be afraid of developing cancer. You may have just been diagnosed. In either case, it’s important to remember that there are ongoing

Learn the differences between physician assistants and nurse practitioners and the important roles they play at Memorial Sloan Kettering.

… Monday, July 6, 2020 At Memorial Sloan Kettering, teamwork is the name of the game. It’s not just one professional taking care of a patient; care teams ensure that every person who walks through the doors is provided for and supported. Vital members of a patient’s care team include physician assistants

Learn how a new imaging approach lights up nerves so they can be avoided during prostate cancer surgery.

… Wednesday, July 9, 2025 Men having  prostate cancer  surgery often fear  side effects  that can result from the procedure. Removing the tumor risks damage to surrounding nerves, resulting in erectile dysfunction and incontinence. Now a new way to light up nerves during the operation may help surgeons

Memorial Sloan Kettering Cancer Center (MSK) researchers published new results that found that individuals with low-risk or intermediate-risk myeloma precursor disease known as monoclonal gammopathy of undetermined significance (MGUS) can convert to high-risk MGUS and progress to multiple myeloma within a five-year window. This research clinically supports recommendations for annual blood tests for all individuals diagnosed with MGUS along with re-assessments of a patient’s clinical-risk status. Their research was published today online in JAMA Oncology.

… Thursday, July 18, 2019 Memorial Sloan Kettering Cancer Center (MSK) researchers published new results that found that individuals with low-risk or intermediate-risk myeloma precursor disease known as monoclonal gammopathy of undetermined significance (MGUS ) can convert to high-risk MGUS and progress

AACR Project GENIE steering committee head and Chair of MSK’s Human Oncology and Pathogenesis Program, Dr. Charles Sawyers, discusses how the first batch of genomic sequencing data fulfills an unmet need in oncology.

… Wednesday, February 15, 2017 In early 2017 a global collaboration of eight cancer centers led by Memorial Sloan Kettering and coordinated by the American Association for Cancer Research (AACR), released its first batch of data: genomic sequencing information on tumors from over 19,000 cancer patients

Scientists have learned that a drug activates a form of highly inflammatory programmed cell death called pyroptosis — a discovery that sheds light on immune function.

… Monday, December 19, 2016 Summary A drug called Val-boroPro triggers an immune response against cancer in mice, but until now, researchers didn’t know the mechanism. The laboratory of Daniel Bachovchin at MSK discovered that Val-boroPro blocks two proteins, DPP8 and DPP9, causing a form of inflammatory

The risk of breast cancer increases as you age. MSK has breast cancer experts with special training and experience treating older patients.

… Thursday, September 7, 2023 When Vivian Moore was diagnosed with breast cancer at age 80, she worried how well she would tolerate the treatments. Living a full life, she was active in her church and busy with sewing, knitting, and sketching. She wanted to continue doing the things she loves. While some

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce that it is ranked among one of the top organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers published by the Institute for Scientific Information at Clarivate.

… Wednesday, November 15, 2023 Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce that it is ranked among one of the top organizations with the greatest number of highly cited scientific researchers worldwide, according to the  annual list  of Highly Cited Researchers published by the 

New findings from researchers at the Sloan Kettering Institute provide insight into a fundamental biological process called the epithelial-mesenchymal transition.

… Wednesday, January 8, 2020 Summary Scientists at the Sloan Kettering Institute have identified the molecular cues that control a fundamental biological process called the epithelial-to-mesenchymal transition. The results may inform the development of therapies designed to target diseases in which this